The company operates a platform that uses mass spectrometry and machine learning, novel probes, genetic and chemical biological technologies to develop innovative drugs for the treatment of chronic diseases, such as cancer, fibrotic disorders, immune-inflammatory disorders, metabolic disorders, and degenerative diseases. Inzen Therapeutics' approach targets cellular turnover, a critical cellular process that can contribute to the development of various diseases, and leverages cutting-edge technologies to develop novel treatments that can improve patient outcomes. The company's mission is to provide medical health practitioners with effective tools to treat a wide range of chronic diseases, thereby improving the quality of life for millions of patients worldwide.